|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/195 | |
| A61K 31/198 | |||
| A61K 31/277 | |||
| A61K 31/435 | |||
| A61P 25/16 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2468271 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12150107.6 |
| Europos patento paraiškos padavimo data | 2008-03-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 894030 P | 2007-03-09 | US |
| (72) |
Roberts, Michael J., US
Pedder, Simon, US
|
| (73) |
Chelsea Therapeutics, Inc.,
3530 Toringdon Way Suite 200, Charlotte, NC 28277,
US
|
| (54) | Pharmaceutical composition comprising droxidopa for the treatment of fibromyalgia |
| Pharmaceutical composition comprising droxidopa for the treatment of fibromyalgia |